3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Motor Activity
7
Esophageal Neoplasms
4
Stomach Neoplasms
3
Smoking Cessation
3
Neoplasms
3
Colonic Neoplasms
3
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Smoking
1
Risk Reduction Behavior
1
Postoperative Complications
1
Patient Preference
1
Pancreatic Neoplasms
1
Obesity
1
Nutrition Disorders
1
Malnutrition
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Insulin Resistance
1
Gynecologic Cancer
1
Gastrointestinal Neoplasms
1
Frailty
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Alcohol Drinking
1
Interventions
Cytarabine
35
Cyclophosphamide
26
Etoposide
18
Radiotherapy
16
Daunorubicin
16
Busulfan
15
Peripheral Blood Stem Cell Transplantation
14
Methotrexate
14
Idarubicin
14
Mercaptopurine
12
Dexamethasone
12
Vincristine
11
Thioguanine
9
Mitoxantrone
9
Doxorubicin
8
Asparaginase
8
Antilymphocyte Serum
8
pegaspargase
7
fludarabine phosphate
7
Prednisolone
7
Polymerase Chain Reaction
7
Filgrastim
7
Cyclosporine
7
Prednisone
6
Mycophenolic Acid
5
Melphalan
5
Leucovorin
5
Gene Expression Profiling
5
Vindesine
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Leukemia
×
Preoperative Exercise
×
Clear all
NCT05649371
2022-12-14
Multiphasic Prehab Allo-HSCT
University of Calgary
Phase NA
Unknown
60 enrolled